Clinical Implications of Angiogenesis in Cancers

References

• AceneroMJGonzalezJFGallegoMGVascular enumeration as a significant prognosticator for invasive breast carcinomaJ Clin Oncol199816168489586879
   PubMed Web of Science ®Google Scholar
• AguayoAKantarjianHMEsteyEHPlasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myeloplastic syndromesCancer20029519233012404286
   PubMed Web of Science ®Google Scholar
• AkagiYLiuWXieKRegulation of vascular endothelial growth factor expression in human colon cancer by interleukin-1 betaBr J Cancer19998015061110408390
   PubMed Web of Science ®Google Scholar
• ArefSEl SherbinyMGodaTSoluble VEGF/sFLt1 ratio is an independent predictor of AML patient outcomeHematology200510131416019458
   PubMed Web of Science ®Google Scholar
• AsaharaTBautersCZhengLPSynergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivoCirculation199592Suppl36571
   Google Scholar
• AsaharaTMasudaHTakahashiTBone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularizationCirc Res199985221810436164
   PubMed Web of Science ®Google Scholar
• BadetJAngiogenin, a potent mediator of angiogenesis. Biological, biochemical and structural propertiesPathol Biol (Paris)1999473455110372403
   PubMedGoogle Scholar
• BergersGBrekkenRMcMahonGMatrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesisNat Cell Biol200027374411025665
   PubMed Web of Science ®Google Scholar
• BouvetMEllisLMNishizakiMAdenovirus-mediated wild-type p 53 gene transfer down-regulates vascular endothelial growth factor expression and inhibits angiogenesis in human colon cancerCancer Res1998582288929622060
   PubMed Web of Science ®Google Scholar
• BurkePADeNardoSJAntiangiogenic agents and their promising potential in combined therapyCrit Rev Oncol Hematol2001391557111418313
   PubMed Web of Science ®Google Scholar
• CarmelietPJainRKAngiogenesis in cancer and other diseasesNature20004072495711001068
   PubMed Web of Science ®Google Scholar
• CasanovasOHicklinDJBergersGDrug resistance by evasion of antiangiogenic targeting of VEGF signaling in late-stage pancreatic islet tumorsCancer Cell2005829930916226705
   PubMed Web of Science ®Google Scholar
• ChenCNChengYMLinMTAssociation of color doppler vascularity index and microvessel density with survival in patients with gastric cancerAnn Surg20022355121811923607
   PubMed Web of Science ®Google Scholar
• CianchiFCortesiniCBechiPUp-regulation of cyclooxygenase 2 gene expression correlates with tumor angiogenesis in human colorectal cancerGastroenterology200112113394711729113
   PubMed Web of Science ®Google Scholar
• CiardielloFBiancoRDamianoVAntiangiogenic and antitumor activity of anti-epidermal growth factor receptor C225 monoclonal antibody in combination with vascular endothelial growth factor antisense oligonucleotide in human GEO colon cancer cellsClin Cancer Res2000637394710999768
   PubMed Web of Science ®Google Scholar
• DabrosinCMargettsPJGauldieJEstradiol increases extracellular levels of vascular endothelial growth factor in vivo in murine mammary cancerInt J Cancer20031075354014520689
   PubMed Web of Science ®Google Scholar
• DanielTOLiuHMorrowJDThromboxane A2 is a mediator of cyclooxygenase-2-dependent endothelial migration and angiogenesisCancer Res1999594574710493510
   PubMed Web of Science ®Google Scholar
• de GramontAVan CutsemEInvestigating the potential of bevacizumab in other indications: metastatic renal cell, non-small cell lung, pancreatic and breast cancerOncology200569Suppl 3465616301835
   PubMed Web of Science ®Google Scholar
• DiasSHattoriKZhuZAutocrine stimulation of VEGFR-2 activates human leukemic cell growth and migrationJ Clin Invest20001065112110953026
   PubMed Web of Science ®Google Scholar
• DicksonCSpencer-DeneBDillonCTyrosine kinase signaling in breast cancer: fibroblast growth factors and their receptorsBreast Cancer Res20002191611250709
   PubMed Web of Science ®Google Scholar
• DirixLYVermeulenPBPawinskiAElevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patientsBr J Cancer199776238439231925
   PubMed Web of Science ®Google Scholar
• DrakeMJRobsonWMehtaPAn open-label phase II study of low-dose thalidomide in androgen-independent prostate cancerBr J Cancer200388822712644816
   PubMed Web of Science ®Google Scholar
• DrevsJZirrgiebelUSchmidt-GersbachCISoluble markers for the assessment of biological activity with PTK787/ZK 222584 (PTK/ZK), a vascular endothelial growth factor receptor (VEGFR) tyrosine kinase inhibitor in patients with advanced colorectal cancer from two phase I trialsAnn Oncol2005165586515705616
   PubMed Web of Science ®Google Scholar
• El-AssalONYamanoiAOnoTThe clinicopathological significance of heparanase and basic fibroblast growth factor expressions in hepatocellular carcinomaClin Cancer Res20017129930511350898
   PubMed Web of Science ®Google Scholar
• EliceriBPCherishDAThe role of alphav integrins during angiogenesis: insights into potential mechanisms of action and clinical developmentJ Clin Invest199910312273010225964
   PubMed Web of Science ®Google Scholar
• EllisLMTakahashiYFenoglioCJVessel counts and vascular endothelial growth factor expression in pancreatic adenocarcinomaEur J Cancer199834337409640218
   PubMed Web of Science ®Google Scholar
• EtohTShibutaKBarnardGFAngiogenin expression in human colorectal cancer: the role of focal macrophage infiltrationClin Cancer Res2000635455110999742
   PubMed Web of Science ®Google Scholar
• FolkmanJTumor angiogenesis: Therapeutic implicationsN Engl J Med1971285118264938153
   PubMed Web of Science ®Google Scholar
• FriessHYamanakaYBuchlerMEnhanced expression of transforming growth factor beta isoforms in pancreatic cancer correlates with decreased survivalGastroenterology19931051846568253361
   PubMed Web of Science ®Google Scholar
• GaspariniGBrooksPCBiganzoliEVascular integrin avb3: a new prognostic indicator in breast cancerClin Cancer Res199842625439829725
   PubMed Web of Science ®Google Scholar
• GeorgeDTargeting PDGF receptors in cancer - rationales and proof of concept clinical trialsAdv Exp Med Biol20035321415112908555
   PubMed Web of Science ®Google Scholar
• GraeplerFVerbeekBGraeterTCombined endostatin/sFlt-1 antiangiogenic gene therapy is highly effective in a rat model of HCCHepatology2005418798615739185
   PubMed Web of Science ®Google Scholar
• GriffithsLStratfordLJPlatelet-derived endothelial cell growth factor thymidine phosphorylase in tumor growth and response to therapyBr J Cancer199776689939310231
   PubMed Web of Science ®Google Scholar
• GuptaKGuptaPWildRBinding and displacement of vascular endothelial growth factor (VEGF) by thrombospondin: effect on human microvascular endothelial cell proliferation and angiogenesisAngiogenesis199931475814517432
   PubMedGoogle Scholar
• HanahanDFolkmanJPatterns of emerging mechanisms of the angiogenic switch during tumorigenesisCell199686353648756718
   PubMed Web of Science ®Google Scholar
• HaubnerRWesterHJWeberWANoninvasive imaging of alpha(v)beta3 integrin expression using 18F-labeled RGD-containing glycopeptide and positron emission tomographyCancer Res2001611781511280722
   PubMed Web of Science ®Google Scholar
• HernbergMVirkkunenPBonoPInterferon alfa-2b three times daily and thalidomide in the treatment of metastatic renal cell carcinomaJ Clin Oncol2003213770614551295
   PubMed Web of Science ®Google Scholar
• Herold-MendeCSteinerHHAndlTExpression and functional significance of vascular endothelial growth factor receptors in human tumor cellsLab Invest19997915738210616207
   PubMed Web of Science ®Google Scholar
• HeymachJVDesaiJManolaJPhase II study of the antiangiogenic agent SU5416 in patients with advanced soft tissue sarcomasClin Cancer Res20041057324015355900
   PubMed Web of Science ®Google Scholar
• HoarFJLipGYBelgoreFCirculating levels of VEGF-A, VEGF-D and soluble VEGF-A receptor (sFIt-1) in human breast cancerInt J Biol Markers2004192293515503825
   PubMed Web of Science ®Google Scholar
• HolashJMaisonpierrePCComptonDVessel co-option, regression and growth in tumors mediated by angiopoietins and VEGFScience19992841994810373119
   PubMed Web of Science ®Google Scholar
• HuQDeyALYangYSoluble vascular endothelial growth factor receptor 1, and not receptor 2, is an independent prognostic factor in acute myeloid leukemia and myelodysplastic syndromesCancer200410018849115112269
   PubMed Web of Science ®Google Scholar
• HurwitzHFehrenbacherLNovotnyWLBevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancerN Engl J Med200435023354215175435
   PubMed Web of Science ®Google Scholar
• HyodoIDoiTEndoHClinical significance of plasma vascular endothelial growth factor in gastrointestinal cancerEur J Cancer1998342041510070308
   PubMed Web of Science ®Google Scholar
• IgarashiMDharDKKubotaHThe prognostic significance of microvessel density and thymidine phosphorylase expression in squamous cell carcinoma of the esophagusCancer1998821225329529012
   PubMed Web of Science ®Google Scholar
• JacobsonJRasmusonTGrankvistKVascular endothelial growth factor as prognostic factor in renal cell carcinomaJ Urol2000163343710604387
   PubMed Web of Science ®Google Scholar
• JainRKSafabakhshNSckellAEndothelial cell death, angiogenesis, and microvascular function after castration in an androgen-dependent tumor: role of vascular endothelial growth factorProc Natl Acad Sci U S A1998951082059724788
   PubMed Web of Science ®Google Scholar
• JohnsonDHFehrenbacherLNovotnyWLRandomized phase II trial comparing bevacizumab plus carboplatin and paclitaxel with carboplatin and paclitaxel alone in previously untreated locally advanced or metastatic non-small-cell lung cancerJ Clin Oncol20042221849115169807
   PubMed Web of Science ®Google Scholar
• KamiyaKKonnoHTanakaTAntitumor effect on human gastric cancer and induction of apoptosis by vascular endothelial growth factor neutralizing antibodyJpn J Cancer Res19999079480010470294
   PubMedGoogle Scholar
• KerbelRSClinical trials of antiangiogenic drugs: opportunities, problems and assessment of initial resultsJ Clin Oncol20011945S51S11560971
   PubMed Web of Science ®Google Scholar
• KerbelRSViloria-PetitAOkadaFEstablishing a link between oncogenes and tumor angiogenesisMol Med19984286959642680
   PubMed Web of Science ®Google Scholar
• KitadaiYHarumaKTokutomiTSignificance of vessel count and vascular endothelial growth factor in human esophageal carcinomasClin Cancer Res1998421952009748139
   PubMed Web of Science ®Google Scholar
• KlementGBaruchelSRakJContinuous low-dose therapy with vinblastine and VEGF receptor-2 antibody induces sustained tumor regression without over toxicityJ Clin Invest2000105R152410772661
   PubMed Web of Science ®Google Scholar
• KochAEHalloranMMHaskellCJAngiogenesis mediated by soluble forms of E-selectin and vascular cell adhesion molecule-1Nature1995376517197543654
   PubMed Web of Science ®Google Scholar
• KonnoSTakebayashiYAibaMClinicopathological and prognostic significance of thymidine phosphorylase and proliferating cell nuclear antigen in gastric carcinomaCancer Lett20011661031111295293
   PubMed Web of Science ®Google Scholar
• KotohTDharDKMasunagaRAntiangiogenic therapy of human esophageal cancers with thalidomide in nude miceSurgery19991255364410330943
   PubMed Web of Science ®Google Scholar
• LeahyKMOrnbergRLWangYCyclooxygenase-2 inhibition by celecoxib reduces proliferation and induces apoptosis in angiogenic endothelial cells in vivoCancer Res2002626253111830509
   PubMed Web of Science ®Google Scholar
• LeeCGHeijnMdi TomasoEAnti-vascular endothelial growth factor treatment augments tumor radiation response under normoxic or hypoxic conditionsCancer Res20006055657011034104
   PubMed Web of Science ®Google Scholar
• LeungDWCachianesGKuangWJVascular endothelial growth factor is a secreted angiogenic mitogenScience1989246130692479986
   PubMed Web of Science ®Google Scholar
• LinAYBrophyNFisherGAPhase II study of thalidomide for unresectable hepatocellular carcinomaCancer20051031192515565573
   PubMed Web of Science ®Google Scholar
• LiottaLAStrackeMLTumor invasion and metastases: biochemical mechanismsCancer Treat Res198840223382908652
   PubMedGoogle Scholar
• LiuYPoonRTLiQBoth angiogenesis- and angiogenesis-independent effects are responsible for hepatocellular carcinoma growth arrest by tyrosine kinase inhibitor PTK787/ZK222584Cancer Res2005653691915867364
   PubMed Web of Science ®Google Scholar
• LodeHNMoehlerTXiangRSynergy between an antiangiogenic integrin alphav antagonist and an antibody-cytokine fusion protein eradicates spontaneous tumor metastasesProc Natl Acad Sci U S A199996159169990069
   PubMed Web of Science ®Google Scholar
• LlovetJMSalaMCastellsLRandomized controlled trial of interferon treatment for advanced hepatocellular carcinomaHepatology20003154810613728
   PubMed Web of Science ®Google Scholar
• LydenDHattoriKDiasSImpaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growthNat Med20017119420111689883
   PubMed Web of Science ®Google Scholar
• MaedaKChungYSOgawaYPrognostic value of vascular endothelial growth factor expression in gastric carcinomaCancer199677858638608475
   PubMed Web of Science ®Google Scholar
• MaedaKChungYSTakatsukaSTumor angiogenesis as a predictor of recurrence in gastric carcinomaJ Clin Oncol199513477817531224
   PubMed Web of Science ®Google Scholar
• MaeharaYKakejiYKabashimaARole of transforming growth factor-beta 1 in invasion and metastasis in gastric carcinomaJ Clin Oncol1999176071410080606
   PubMed Web of Science ®Google Scholar
• MaisonpierrePCSuriCJonesPFAngiopoietin-2, a natural antagonist for Tie-2 that disrupts in vivo angiogenesisScience19972755609204896
   PubMedGoogle Scholar
• MatsumotoKKonnoHTanakaTCombination therapy with vascular endothelial growth factor neutralizing antibody and mitomycin C on human gastric cancer xenograftJpn J Cancer Res2000917485210920283
   PubMedGoogle Scholar
• MatsumuraMChibaYLuCPlatelet-derived endothelial cell growth factor/thymidine phosphorylase expression correlated with tumor angiogenesis and macrophage infiltration in colorectal cancerCancer Lett199812855639652793
   PubMed Web of Science ®Google Scholar
• MillerKDChapLIHolmesFARandomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancerJ Clin Oncol200523792915681523
   PubMed Web of Science ®Google Scholar
• MillerKDTrigoJMWheelerCA multicenter phase II trial of ZD6474, a vascular endothelial growth factor receptor-2 and epidermal growth factor receptor tyrosine kinase inhibitor, in patients with previously treated metastatic breast cancerClin Cancer Res20051133697615867237
   PubMed Web of Science ®Google Scholar
• MolicaSVaccaARibattiDPrognostic value of enhanced bone marrow angiogenesis in early B-cell chronic lymphocytic leukemiaBlood200210033445112384436
   PubMed Web of Science ®Google Scholar
• NguyenMWatanabeHBudsonAEElevated levels of an angiogenic peptide, basic fibroblast growth factor, in the urine of patients with a wide spectrum of cancersJ Natl Cancer Inst199486356617508518
   PubMed Web of Science ®Google Scholar
• O'ReillyMSHolmgrenLChenCAngiostatin induces and sustains dormancy of human primary tumors in miceNat Med19962689928640562
   PubMed Web of Science ®Google Scholar
• O'ReillyMSBoehmTShingYEndostatin: an endogenous inhibitor of angiogenesis and tumor growthCell199788277859008168
   PubMed Web of Science ®Google Scholar
• ObaKKonnoHTanakaTPrevention of liver metastasis of human colon cancer by selective matrix metalloproteinase inhibitor MMI-166Cancer Lett2002175455111734335
   PubMed Web of Science ®Google Scholar
• OguraOTakebayashiYSameshimaTPreoperative assessment of vascularity by color Doppler ultrasonography in human rectal carcinomaDis Colon Rectum2001445384611330581
   PubMed Web of Science ®Google Scholar
• Ozvegy-LaczkaCCserepesJElkindNBTyrosine kinase inhibitor resistance in cancer: role of ABC multidrug transportersDrug Resist Updat20058152615939339
   PubMed Web of Science ®Google Scholar
• PalSClaffeyKPDvorakHFThe von Hippel-Lindau gene product inhibits vascular permeability factor/vascular endothelial growth factor expression in renal cell carcinoma by blocking protein kinase C pathwaysJ Biol Chem199727227509129346879
   PubMed Web of Science ®Google Scholar
• PapapetropoulosAGarcia-CardenaGDenglerTJDirect actions of angiopoietin-1 on human endothelium: Evidence for network stabilization, cell survival, and interaction with other angiogenic growth factorsLab Invest1999792132310068209
   PubMed Web of Science ®Google Scholar
• Perez-AtaydeARSallanSETedrowUSpectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemiaAm J Pathol1997150815219060819
   PubMed Web of Science ®Google Scholar
• PetersBADiazLAPolyakKContribution of bone marrow-derived endothelial cells to human tumor vasculatureNat Med200511261215723071
   PubMed Web of Science ®Google Scholar
• PietraNSarliLCaruanaPIs tumour angiogenesis a prognostic factor in patients with colorectal cancer and no involved nodes?Eur J Surg2000166552610965834
   PubMedGoogle Scholar
• PoonRTFanSTWongJClinical implications of circulating angiogenic factors in cancer patientsJ Clin Oncol20011912072511181687
   PubMed Web of Science ®Google Scholar
• PoonRTHoJWTongCSPrognostic significance of serum vascular endothelial growth factor and endostatin in patients with hepatocellular carcinomaBr J Surg20049113546015376182
   PubMed Web of Science ®Google Scholar
• PoonRTLauCPCheungSTQuantitative correlation of serum levels and tumor expression of vascular endothelial growth factors in patients with hepatocellular carcinomaCancer Res2003633121612810638
   PubMed Web of Science ®Google Scholar
• PoonRTLauCPHoJWTissue factor expression correlates with tumor angiogenesis and invasiveness in human hepatocellular carcinomaClin Cancer Res2003953394514614019
   PubMed Web of Science ®Google Scholar
• PoonRTNgIOLauCCorrelation of serum basic fibroblast growth factor levels with clinicopathologic features and postoperative recurrence in hepatocellular carcinomaAm J Surg2001a18229830411587697
   PubMed Web of Science ®Google Scholar
• PoonRTNgIOLauCSerum vascular endothelial growth factor predicts venous invasion in hepatocellular carcinoma: a prospective studyAnn Surg2001b2332273511176129
   PubMed Web of Science ®Google Scholar
• PoonRTNgIOLauCTumor microvessel density as a predictor of recurrence after resection of hepatocellular carcinoma: A prospective studyJ Clin Oncol20022017758511919234
   PubMed Web of Science ®Google Scholar
• RabitschWSperrWRLechnerKBone marrow microvessel density and its prognostic significance in AMLLeuk Lymphoma20044513697315359635
   PubMed Web of Science ®Google Scholar
• RakJWMitsuhashiYSheehanCOncogenes and tumor angiogenesis: differential modes of vascular endothelial growth factor up-regulation in ras-transformed epithelial cells and fibroblastsCancer Res200060490810667605
   PubMed Web of Science ®Google Scholar
• ReirizABRichterMFFernandesSPhase II study of thalidomide in patients with metastatic malignant melanomaMelanoma Res2004145273115577325
   PubMed Web of Science ®Google Scholar
• RuzinovaMBSchoerRAGeraldWEffect of angiogenesis inhibition by Id loss and the contribution of bone-marrow-derived endothelial cells in spontaneous murine tumorsCancer Cell200342778914585355
   PubMed Web of Science ®Google Scholar
• SaitoHTsujitaniSOkaSThe expression of transforming growth factor-beta1 is significantly correlated with the expression of vascular endothelial growth factor and poor prognosis of patients with advanced gastric carcinomaCancer19998614556210526273
   PubMed Web of Science ®Google Scholar
• SchmitzVWangLBarajasMTreatment of colorectal and hepatocellular carcinomas by adenoviral mediated gene transfer of endostatin and angiostatin-like molecule in miceGut200453561715016752
   PubMed Web of Science ®Google Scholar
• SeoYBabaHFukudaTHigh expression of vascular endothelial growth factor is associated with liver metastasis and a poor prognosis for patients with ductal pancreatic adenocarcinomaCancer20008822394510820344
   PubMed Web of Science ®Google Scholar
• SetoSOnoderaHKaidoTTissue factor expression in human colorectal carcinoma: correlation with hepatic metastasis and impact on prognosisCancer20008829530110640960
   PubMed Web of Science ®Google Scholar
• ShaheenRMAhmadSALiuWInhibited growth of colon cancer carcinomatosis by antibodies to vascular endothelial and epidermal growth factor receptorsBr J Cancer200185584911506500
   PubMed Web of Science ®Google Scholar
• ShaheenRMTsengWWDavisDWTyrosine kinase inhibition of multiple angiogenic growth factor receptors improves survival in mice bearing colon cancer liver metastases by inhibition of endothelial cell survival mechanismsCancer Res2001611464811245452
   PubMed Web of Science ®Google Scholar
• ShiWSiemannDWTargeting the tumor vasculature: enhancing antitumor efficacy through combination treatment with ZD6126 and ZD6474In Vivo20051910455016277020
   PubMed Web of Science ®Google Scholar
• ShimadaHTakedaANabeyaYClinical significance of serum vascular endothelial growth factor in esophageal squamous cell carcinomaCancer200192663911505413
   PubMed Web of Science ®Google Scholar
• ShimadaHTakedaAShiratoriTPrognostic significance of serum thymidine phosphorylase concentration in esophageal squamous cell carcinomaCancer20029419475411932896
   PubMed Web of Science ®Google Scholar
• ShimoyamaSGansaugeFGansaugeSIncreased angiogenin expression in pancreatic cancer is related to cancer aggressivenessCancer Res199656270368665497
   PubMed Web of Science ®Google Scholar
• ShweikiDItinASofferDVascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesisNature199235984351279431
   PubMed Web of Science ®Google Scholar
• ShweikiDNeemanMItinAInduction of vascular endothelial growth factor expression by hypoxia and by glucose deficiency in multicell spheroids: implications for tumor angiogenesisProc Natl Acad Sci U S A199592768727531342
   PubMed Web of Science ®Google Scholar
• SinghalSMehtaJDesikanRAntitumor activity of thalidomide in refractory multiple myelomaN Engl J Med1999341156771
   Web of Science ®Google Scholar
• SipkinsDAChereshDAKazamiMRDetection of tumor angiogenesis in vivo by avb3-targeted magnetic resonance imagingNat Med1998462369585240
   PubMed Web of Science ®Google Scholar
• SolorzanoCCBakerCHBrunsCJInhibition of growth and metastasis of human pancreatic cancer growing in nude mice by PTK 787/ZK222584, an inhibitor of the vascular endothelial growth factor receptor tyrosine kinasesCancer Biother Radiopharm2001163597011776753
   PubMed Web of Science ®Google Scholar
• StadlerWMCaoDVogelzangNJA randomized phase II trial of the antiangiogenic agent SU5416 in hormone-refractory prostate cancerClin Cancer Res20041033657015161690
   PubMed Web of Science ®Google Scholar
• StrumbergDRichlyHHilgerRAPhase I clinical and pharmacokinetic study of the Novel Raf kinase and vascular endothelial growth factor receptor inhibitor BAY 43-9006 in patients with advanced refractory solid tumorsJ Clin Oncol2005239657215613696
   PubMed Web of Science ®Google Scholar
• TakebayashiYAkiyamaSAkibaSClinicopathologic and prognostic significance of an angiogenic factor, thymidine phosphorylase, in human colorectal carcinomaJ Natl Cancer Inst1996881110178757190
   PubMed Web of Science ®Google Scholar
• TakebayashiYAklyamaSYamadaKAngiogenesis as an unfavorable prognostic factor in human colorectal carcinomaCancer199678226318673996
   PubMed Web of Science ®Google Scholar
• TangTCPoonRTLauCPTumor cyclooxygenase-2 levels correlate with tumor invasiveness in human hepatocellular carcinomaWorld J Gastroenterol200511189690215800977
   PubMed Web of Science ®Google Scholar
• te VeldeEAReijerkerkABrandsmaDEarly endostatin treatment inhibits metastatic seeding of murine colorectal cancer cells in the liver and their adhesion to endothelial cellsBr J Cancer2005927293515700042
   PubMed Web of Science ®Google Scholar
• ThomasJPArzoomanianRZAlbertiDPhase I pharmacokinetic and pharmacodynamic study of recombinant human endostatin in patients with advanced solid tumorsJ Clin Oncol2003212233112525513
   PubMed Web of Science ®Google Scholar
• ThomasALMorganBHorsfieldMAPhase I study of the safety, tolerability, pharmacokinetics, and pharmacodynamics of PTK787/ZK 222584 administered twice daily in patients with advanced cancerJ Clin Oncol20052341627115867205
   PubMed Web of Science ®Google Scholar
• TokunagaTOshikaYAbeYVascular endothelial growth factor (VEGF) mRNA isoform expression pattern is correlated with liver metastasis and poor prognosis in colon cancerBr J Cancer19987799810029528847
   PubMed Web of Science ®Google Scholar
• TorresCWangHTurnerJPrognostic significance and effect of chemoradiotherapy on microvessel density (angiogenesis) in esophageal Barrett's esophagus-associated adenocarcinoma and squamous cell carcinomaHum Pathol199930753810414493
   PubMed Web of Science ®Google Scholar
• VeikkolaTKarkkainenMCleasson-WelshLRegulation of angiogenesis via vascular endothelial growth factor receptorsCancer Res2000602031210667560
   PubMed Web of Science ®Google Scholar
• VerstovsekSKantarjianHManshouriTPrognostic significance of cellular vascular endothelial growth factor expression in chronic phase chronic myeloid leukemiaBlood2002992265711877311
   PubMed Web of Science ®Google Scholar
• WangLTangZYQinLXHigh-dose and long-term therapy with interferon-alfa inhibits tumor growth and recurrence in nude mice bearing human hepatocellular carcinoma xenografts with high metastatic potentialHepatology20003243810869287
   PubMed Web of Science ®Google Scholar
• WeidnerNSemplePWelchWTumor angiogenesis and metastasis: correlation in invasive breast carcinomaN Engl J Med1991324181701519
   PubMed Web of Science ®Google Scholar
• WertherKChristensenIJNielsenHJPrognostic impact of matched preoperative plasma and serum VEGF in patients with primary colorectal carcinomaBr J Cancer2002864172311875709
   PubMed Web of Science ®Google Scholar
• WuJRicherJHorwitzKBHyderSMProgestin-dependent induction of vascular endothelial growth factor in human breast cancer cells: preferential regulation by progesterone receptor BCancer Res20046422384415026368
   PubMed Web of Science ®Google Scholar
• YamamotoYToiMKondoSConcentrations of vascular endothelial growth factor in the sera of normal controls and cancer patientsClin Cancer Res1996282169816236
   PubMed Web of Science ®Google Scholar
• YamanakaYFriessHBuchlerMOverexpression of acidic and basic fibroblast growth factors in human pancreatic cancer correlates with advanced tumor stageCancer Res1993535289967693336
   PubMed Web of Science ®Google Scholar
• YoshikawaTTsuburayaAKobayashiOPlasma concentrations of VEGF and bFGF in patients with gastric carcinomaCancer Lett200015371210779624
   PubMed Web of Science ®Google Scholar
• ZangariMAnaissieEStopeckAPhase II study of SU5416, a small molecule vascular endothelial growth factor tyrosine kinase receptor inhibitor, in patients with refractory multiple myelomaClin Cancer Res2004101 Pt 1889514734456
   PubMed Web of Science ®Google Scholar